Pachyonychia congenita (PC) consists of a group of inherited ectodermal disorders characterized by hypertrophic nail dystrophy. The two most common forms of PC are PC-1 (or Jadassohn-Lewandowsky type) and PC-2 (or Jackson-Lawler type), which are both inherited through an autosomal dominant trait. In the PC-1 form, the nails are normal in birth, but within several months they become thickened and discolored, with increased transverse curvature and subungual hyperkeratosis ("pincer nail" effect).62 Typical associated features include focal symmetric palmoplantar keratoderma with or without hyperhidrosis, angular cheilitis, follicular hyperkeratosis, hoarseness, and oral leukokeratosis. Compared with the phenotype of PC-1, the PC-2 form has less severe nail thickening, minimal oral involvement, and milder keratoderma.63 It is readily distinguished by the presence of multiple steatocystomas (manifesting usually during puberty), pili torti, and, in some cases, erupted teeth at birth. We now know that the genetic cause of PC are mutations in 4 differentiation-specific keratin genes that are expressed by the affected epithelia. PC-1 is due to mutations of the keratin 16 (K16) gene located on chromosome 12 or its expression pattern, the K6a isoform of K6 located on chromosome 17.64 Similarly, PC-2 is due to mutations in keratin 17 (K17) gene or the K6b isoform, which are located on chromosomes 17 and 12, respectively.65 Most of the reported mutations affect the highly conserved peptide sequences at either end of the helical rod domain of the keratin molecule, sites that are critical for the intermediate filament assembly. Phenotypic differences, however, have been found in pedigrees carrying mutations in the K16 or K17 genes. For example, K16 mutations can present as focal keratoderma in the absence of nail changes or other features of PC-1.66 Similarly, K17 gene mutations have been identified in families with steatocystomas without any nail or other ectodermal abnormalities.67 The reasons for these differences are unknown, but variations in severity may correspond to polymorphism in ancillary components of the cytoskeleton or to the existence of mutations in internal parts of the rod domain rather than in the helix boundary motifs.68 The latter hypothesis is supported by the detection of mutations in the central portion of the K16 rod domain in a case of PC with delayed onset of symptoms (age, >6 years).69 In addition to the location of the mutation within the keratin gene, the diversity of clinical features suggests that other genetic or environmental unknown factors could be crucial in the ultimate clinical expression of the disease.